Dolutegravir: Uses, Dosage, Side Effects & Interactions

Key Points About Dolutegravir Medication

Dolutegravir is a prescription medication used to manage HIV infections, including both HIV-1 and HIV-2. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs), which help control the virus by preventing it from multiplying in the body. Typically, Dolutegravir is prescribed alongside other antiretroviral medications to enhance its effectiveness. It is essential to take this medication exactly as instructed by your healthcare provider. Since side effects can occur, regular follow-ups and monitoring are highly recommended to ensure safe and effective treatment.

Names of Dolutegravir Medication

US Brand Name: Tivicay

Generic Name: Dolutegravir

The generic name refers to the active ingredient in the medication. In this case, Dolutegravir is the generic name, often listed in parentheses on prescription labels or packaging.

Pharmacologic Category of Dolutegravir

Integrase Strand Transfer Inhibitors (INSTIs)

Dolutegravir Dosage Guidelines

Dolutegravir is prescribed for various types of HIV infections and co-infections. The dosage may vary depending on the specific condition being treated and individual patient factors. Always consult your healthcare provider before making any changes to your dosage. For personalized guidance, you can also schedule a telemedicine appointment with one of our providers.

Dolutegravir Dosage for HIV-1 and HIV-2 Infections

Initial treatment: 50 mg once daily, with or without food.

For patients with resistance to other integrase inhibitors: 50 mg twice daily.

Dolutegravir Dosage for Opportunistic Infections

Co-infection with opportunistic infections (e.g., tuberculosis): 50 mg once or twice daily, depending on other medications being taken.

Dolutegravir Dosage for Chronic HIV Infection

Standard treatment: 50 mg once daily.

Dolutegravir Dosage for Acute HIV Infection

Initial treatment: 50 mg once daily, often combined with other antiretroviral medications.

Dolutegravir Dosage for Multidrug-Resistant HIV

For patients with multidrug-resistant HIV: 50 mg twice daily.

Dolutegravir Dosage for Co-Infection with Hepatitis B or Hepatitis C

Standard treatment: 50 mg once daily, typically combined with other medications to address both HIV and hepatitis.

Dosage Forms and Strengths of Dolutegravir

Tablet: 10 mg, 25 mg, 50 mg

Tablet for oral suspension: 5 mg

How to Take Dolutegravir: Administration Instructions

Take Dolutegravir exactly as prescribed by your healthcare provider. It can be taken with or without food. If you are using antacids, laxatives, or supplements containing calcium or iron, take Dolutegravir at least two hours before or six hours after these products to avoid interference with absorption. Do not skip doses, as this may reduce the medication’s effectiveness. If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Consistency is key to ensuring the medication works effectively.

Dolutegravir Side Effects and Adverse Reactions

Like all medications, Dolutegravir may cause side effects. While some are common and mild, others are rare but potentially serious. If you experience severe side effects, contact your healthcare provider immediately or seek emergency medical attention.

Common side effects (1-10%): Headache, nausea, diarrhea, and difficulty sleeping.

Less common side effects (0.1-1%): Fatigue, dizziness, and abnormal liver function test results.

Rare but serious side effects (<0.1%): Severe allergic reactions, liver problems, depression, or suicidal thoughts.

If you notice any unusual symptoms or side effects, consult your healthcare provider promptly. You may also schedule a telemedicine appointment for further evaluation and guidance.

Contraindications for Dolutegravir

A contraindication refers to a condition or situation in which a medication, such as Dolutegravir, should not be used because it may cause harm. If you have any of the following conditions, you should avoid taking Dolutegravir unless specifically directed by your healthcare provider. It is crucial to share your complete medical history, especially during telemedicine consultations, to ensure Dolutegravir is safe and appropriate for you.

Severe liver disease: Dolutegravir is metabolized by the liver. If you have severe liver problems, taking this medication could further impair liver function and should generally be avoided.

Hypersensitivity or allergic reactions: Avoid Dolutegravir if you have experienced an allergic reaction to it or any of its components. Symptoms of an allergic reaction may include rash, fever, or difficulty breathing. If you suspect an allergic reaction, seek medical attention immediately.

Use of dofetilide (Tikosyn): Dolutegravir can increase the levels of dofetilide in the blood, which may lead to serious heart complications, including potentially life-threatening arrhythmias. For this reason, the combination of these medications is strictly contraindicated.

Dolutegravir Drug Interactions

Dolutegravir can interact with a variety of medications, which may either reduce its effectiveness or increase the risk of side effects. To ensure your safety, inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and dietary supplements. Below are some common drug interactions associated with Dolutegravir:

1. Metformin (Glucophage): Dolutegravir can raise metformin levels in the blood, which may require dose adjustments to avoid side effects such as low blood sugar. Your healthcare provider will monitor your blood sugar levels and adjust your treatment as needed.
2. Rifampin (Rifadin): Rifampin can decrease the levels of Dolutegravir in your body, potentially reducing its effectiveness. If these medications must be used together, your provider may increase your Dolutegravir dosage to compensate.
3. Antacids containing magnesium or aluminum (Maalox, Mylanta): These antacids can interfere with the absorption of Dolutegravir, making it less effective. To avoid this interaction, take Dolutegravir at least two hours before or six hours after taking antacids.
4. Calcium supplements: Similar to antacids, calcium supplements can reduce the absorption of Dolutegravir. To ensure the medication works properly, space out the timing of these supplements and Dolutegravir as directed by your provider.
5. Carbamazepine (Tegretol): This anti-seizure medication can lower Dolutegravir levels, diminishing its effectiveness. Your healthcare provider may adjust your Dolutegravir dosage to maintain its therapeutic effect.

Dolutegravir and Pregnancy

Is it safe to take Dolutegravir during pregnancy?

Dolutegravir is generally considered safe for use during pregnancy, but certain factors should be carefully evaluated. Early studies raised concerns about a potential risk of neural tube defects (which affect the brain and spine) when Dolutegravir was taken during the first trimester. However, more recent research indicates that this risk is extremely low. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of Dolutegravir with your healthcare provider. They will help you make an informed decision based on your individual health needs and circumstances.

Dolutegravir While Breastfeeding

Is it safe to take Dolutegravir while breastfeeding?

Dolutegravir does pass into breast milk, but its effects on breastfeeding infants are not yet fully understood. The World Health Organization (WHO) recommends Dolutegravir as part of antiretroviral therapy for breastfeeding mothers with HIV, as the benefits of controlling the virus typically outweigh any potential risks. To determine the best course of action for you and your baby, consult your healthcare provider. They will guide you in making the safest and most effective choice for your situation.

Estimated Cost of Dolutegravir Medication

The cost of **Dolutegravir** can vary depending on your location and the pharmacy you use. Without insurance, a 30-day supply of Dolutegravir (50 mg tablets) typically costs between $2,000 and $2,500. However, using a GoodRx coupon may lower the price to approximately $1,800 to $2,000. To get the most accurate pricing, check with your pharmacy directly, and consider using a coupon to help reduce your out-of-pocket expenses.

Possible Alternatives to Dolutegravir

If **Dolutegravir** is not the right option for you, there are other **HIV treatment options** available. It’s essential to consult your healthcare provider before making any changes to your treatment plan. Below are some alternatives tailored to specific conditions:

HIV, AIDS, HIV-1 Infection, HIV-2 Infection

Other antiretroviral medications, such as Bictegravir (Biktarvy), Raltegravir (Isentress), or Darunavir (Prezista), may be suitable alternatives. In addition to medication, adopting healthy lifestyle habits—such as eating a balanced diet, exercising regularly, and avoiding smoking or excessive alcohol consumption—can support your overall health while managing HIV.

Opportunistic Infections

For opportunistic infections, your healthcare provider may prescribe antibiotics, antifungals, or antivirals, depending on the specific infection. Preventive measures, such as staying up to date on vaccinations and maintaining a strong immune system through proper nutrition and adequate rest, are equally important.

Chronic HIV Infection

Managing chronic HIV often involves combination antiretroviral therapy (ART) with medications like Tenofovir (Viread) or Emtricitabine (Emtriva). Regular monitoring of your viral load and CD4 count is crucial to ensure your treatment plan is effective and to make adjustments if needed.

Acute HIV Infection

Early treatment with ART, including medications such as Efavirenz (Sustiva) or Lamivudine (Epivir), can help control the virus and prevent further progression. Prompt intervention is critical, so seek medical attention immediately if you suspect an acute HIV infection.

Multidrug-Resistant HIV

For individuals with multidrug-resistant HIV, newer medications like Fostemsavir (Rukobia) or Ibalizumab (Trogarzo) may be recommended. These drugs are specifically designed to target and manage resistant strains of the virus, offering hope for those with limited treatment options.

Co-Infection with Hepatitis B

Medications such as Tenofovir (Viread) or Entecavir (Baraclude) can effectively treat both HIV and hepatitis B. Your healthcare provider will closely monitor your liver function to ensure the treatment is both safe and effective for your specific needs.

Co-Infection with Hepatitis C

Direct-acting antivirals (DAAs), such as Sofosbuvir (Sovaldi) or the combination of Ledipasvir and Sofosbuvir (Harvoni), may be used alongside HIV treatment to manage hepatitis C. Treating both conditions simultaneously is vital for achieving the best possible health outcomes.

Recent Updates on Dolutegravir Research

Ongoing research continues to explore the safety and effectiveness of **Dolutegravir**, particularly in special populations such as pregnant women and individuals with multidrug-resistant HIV. A 2021 study reaffirmed that Dolutegravir remains highly effective in controlling HIV across diverse patient groups, including those with drug-resistant strains. Additionally, researchers are investigating the long-term effects of Dolutegravir on liver function and its interactions with other medications commonly used in **HIV antiretroviral therapy**. While these findings are encouraging, it’s important to stay informed and discuss any questions or concerns with your healthcare provider.

James Kingsley

Learn More